Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carisbamate in Essential Tremor
NCT00524056Phase 2Completed
- Sponsor
- SK Life Science, Inc.
- Start
- Aug 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of carisbamate in essential tremor (ET), sponsored by SK Life Science, Inc.. Started Aug 2007; status: completed.
02
Drugs
carisbamate
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT00524056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524056.